VAN DEN BOOGAARD, F. E., BRANDS, X., SCHULTZ, M. J., LEVI, M., ROELOFS, J. J. T. H., VAN 'T VEER, C., & VAN DER POLL, T. (2011). Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti‐inflammatory and antimicrobial effects in murine pneumococcal pneumonia. Journal of thrombosis and haemostasis, 9(1), 122-132. https://doi.org/10.1111/j.1538-7836.2010.04089.x
Chicago-Zitierstil (17. Ausg.)VAN DEN BOOGAARD, F. E., X. BRANDS, M. J. SCHULTZ, M. LEVI, J. J. T. H. ROELOFS, C. VAN 'T VEER, und T. VAN DER POLL. "Recombinant Human Tissue Factor Pathway Inhibitor Exerts Anticoagulant, Anti‐inflammatory and Antimicrobial Effects in Murine Pneumococcal Pneumonia." Journal of Thrombosis and Haemostasis 9, no. 1 (2011): 122-132. https://doi.org/10.1111/j.1538-7836.2010.04089.x.
MLA-Zitierstil (9. Ausg.)VAN DEN BOOGAARD, F. E., et al. "Recombinant Human Tissue Factor Pathway Inhibitor Exerts Anticoagulant, Anti‐inflammatory and Antimicrobial Effects in Murine Pneumococcal Pneumonia." Journal of Thrombosis and Haemostasis, vol. 9, no. 1, 2011, pp. 122-132, https://doi.org/10.1111/j.1538-7836.2010.04089.x.